20 June 2013
Keywords: Wilex, UCB Pharma, MEK inhibitor WX-554
Article | 05 August 2009
German biopharmaceutical firm Wilex has filed an application with the German Federal Institute for Drugs and Medical Devices (BfArM) for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 August 2009
6 August 2009
19 June 2013
© 2013 thepharmaletter.com